Navis Bio
Clinical AI that finds what's hidden
Küsnacht, Zurich, Switzerland
Navis Bio is an AI-powered biopharma intelligence company providing agentic AI solutions for translational medicine. It uses agentic AI to extract insights from scientific literature, clinical trials, and drug development data, and provides custom business process automation for biopharma organizations.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →How We Help
Problem Statement
Navis Bio enables biopharma organizations to make better, data-driven decisions for drug discovery and development by extracting non-obvious insights from scientific literature, clinical trials, and drug development data.
Core Technology
Agentic AI
Key Differentiators
Uses agentic AI for autonomous task execution rather than passive assistance; Occupies a distinct niche in translational research data integration and intelligence rather than de novo drug discovery; Developed open-source AI tools for translational research and biomedical data analysis; Enables direct querying of clinical trial data with natural language interfaces
Clinical Focus
translational medicine; clinical trials
Company Info
- Business Model
- B2B SaaS
- Founded
- 2024
Clinical & IP
Clinical Validation
Integrates with CTTI's AACT database; Founded 2024; DayOne Accelerator 2025 cohort; SOC2 certified
MedStartr Index Score
?What do you think of Navis Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.